Publications by authors named "Brian Lichty"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

11,793

Total Likes

241

Extended Reach

597,795

Social Features

114
A
A universal boosting strategy for adoptive T cell therapy using a paired vaccine/chimeric antigen receptor.
Rebecca Burchett, Claire G Morris, Mira Ishak, Nickolas J Serniuck, Derek T Cummings, Brian D Lichty

Cancer Immunol Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BiTE-secreting T cells rationally combine with PD-1 blockade and vaccine boosting to reshape antitumor immunity in ovarian cancer.
Jessie L Chiello, Nijamuddin Shaikh, Justine Jacobi, Nicole Gaulin, Gabriel Santos, Brian Lichty

Mol Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trial.
Mangalakumari Jeyanathan, Sam Afkhami, Michael R D'Agostino, Imran Satia, Dominik K Fritz, Brian D Lichty

Nat Commun· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AeroVax: study protocol for a randomised, double-blind, placebo-controlled, phase 2 trial to evaluate safety and immunogenicity of a next-generation COVID-19 vaccine delivered by inhaled aerosol to humans.
Adam S Komorowski, Lawrence Mbuagbaw, Mangalakumari Jeyanathan, Sam Afkhami, Marilyn Swinton, Brian D Lichty

ERJ Open Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved thermal stabilization of VSV-vector with enhanced vacuum drying in pullulan and trehalose-based films.
Jeremy A Iwashkiw, Abdulhamid O Mohamud, Natallia Kazhdan, Aaisha Ameen, Jody E Beecher, Brian D Lichty

Sci Rep· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX.
Jack T Whelan, Ragunath Singaravelu, Fuan Wang, Adrian Pelin, Levi A Tamming, Brian D Lichty

Front Immunol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2.
Sam Afkhami, Michael R D'Agostino, Ali Zhang, Hannah D Stacey, Art Marzok, Brian D Lichty

Cell· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural killer T cell immunotherapy combined with IL-15-expressing oncolytic virotherapy and PD-1 blockade mediates pancreatic tumor regression.
Adam Nelson, Simon Gebremeskel, Brian D Lichty, Brent Johnston

J Immunother Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans.
Mangalakumari Jeyanathan, Dominik K Fritz, Sam Afkhami, Emilio Aguirre, Karen J Howie, Brian D Lichty

JCI Insight· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCR6 by increasing retention of memory CD8 T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer.
Ravikumar Muthuswamy, Aj Robert McGray, Sebastiano Battaglia, Wenjun He, Anthony Miliotto, Brian D Lichty

J Immunother Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic anti-tumor efficacy of oncolytic influenza viruses and B7-H3 immune- checkpoint inhibitors against IC-resistant lung cancers.
Dörthe Masemann, Ramona Meissner, Tanja Schied, Brian D Lichty, Ulf R Rapp

Oncoimmunology· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA editing enzyme APOBEC3A promotes pro-inflammatory M1 macrophage polarization.
Emad Y Alqassim, Shraddha Sharma, A N M Nazmul H Khan, Tiffany R Emmons, Eduardo Cortes Gomez, Brian D Lichty

Commun Biol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of Tumor Antigen-Specific T-Cell Responses After Oncolytic Vaccination.
Jonathan G Pol, Byram W Bridle, Brian D Lichty

Methods Mol Biol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spray dried VSV-vectored vaccine is thermally stable and immunologically active in vivo.
Steven P Toniolo, Sam Afkhami, Michael R D'Agostino, Brian D Lichty, Emily D Cranston

Sci Rep· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioning.
Jonathan G Pol, Matthew J Atherton, Kyle B Stephenson, Byram W Bridle, Samuel T Workenhe, Brian D Lichty

J Immunother Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measles Vaccines Designed for Enhanced CD8 T Cell Activation.
Elena Busch, Kristina D Kubon, Johanna K M Mayer, Gemma Pidelaserra-Martí, Jessica Albert, Brian D Lichty

Viruses· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endogenous T cells prevent tumor immune escape following adoptive T cell therapy.
Scott R Walsh, Boris Simovic, Lan Chen, Donald Bastin, Andrew Nguyen, Brian D Lichty

J Clin Invest· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer.
A J Robert McGray, Ruea-Yea Huang, Sebastiano Battaglia, Cheryl Eppolito, Anthony Miliotto, Brian D Lichty

J Immunother Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excipient selection for thermally stable enveloped and non-enveloped viral vaccine platforms in dry powders.
Steven P Toniolo, Sam Afkhami, Ahmad Mahmood, Cécile Fradin, Brian D Lichty

Int J Pharm· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and applications of oncolytic Maraba virus vaccines.
Jonathan G Pol, Matthew J Atherton, Byram W Bridle, Kyle B Stephenson, Fabrice Le Boeuf, Brian D Lichty

Oncolytic Virother· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials.
Jonathan G Pol, Sergio A Acuna, Beta Yadollahi, Nan Tang, Kyle B Stephenson, Brian D Lichty

Oncoimmunology· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consecutive Spray Drying to Produce Coated Dry Powder Vaccines Suitable for Oral Administration.
Daniel A LeClair, Emily D Cranston, Brian D Lichty, Zhou Xing, Michael R Thompson

ACS Biomater Sci Eng· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transforming the prostatic tumor microenvironment with oncolytic virotherapy.
Matthew J Atherton, Kyle B Stephenson, Fanny Tzelepis, David Bakhshinyan, Jake K Nikota, Brian D Lichty

Oncoimmunology· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic influenza virus infection restores immunocompetence of lung tumor-associated alveolar macrophages.
Dörthe Masemann, Katharina Köther, Meike Kuhlencord, Georg Varga, Johannes Roth, Brian Dennis Lichty

Oncoimmunology· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis